PT
ProQR Therapeutics BV
🇺🇸XNAS.PRQRUnited StatesHealthcare
$1.82USDdown -0.04 (-2.15%)ClosedEnd of day9:48 PM
Price$1.82-0.04 (-2.15%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- NL0010872495
- CUSIP
- N71542109
Company
- Employees
- 186
- Headquarters
- Leiden, United States
- Website
- https://www.proqr.com
- CEO
- Mr. Daniel Anton de Boer
Market
- Shares outstanding
- 141.1M
- Market cap
- $256.84M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $256.84M
- EPS LTM
- -€0.38
- P/E LTM
- -4.23
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- €18.53M+12.4%up year on year
- Net income
- -€42.32M-6.67%down year on year
- Gross margin
- 88.68%
- Free cash flow
- -€50M-16.43%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.